| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/25/2000 | US6054130 Non-splicing variants of gp350/220 |
| 04/25/2000 | US6054126 A synthetic polypeptide containing the conformational epitope recognized by monoclonal antibody mab 17-82 for neutralizing antibodies in an avian host; stimulating an immune response against infectious bursal disease virus in poultry |
| 04/25/2000 | US6054125 Purified mite allergen |
| 04/25/2000 | US6054123 Haemophilus influenzae dimethylsulphoxide reductase enzyme |
| 04/25/2000 | CA2110386C Method for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides |
| 04/25/2000 | CA2098021C Composition used as a therapeutic agent against chronic viral hepatic diseases |
| 04/25/2000 | CA2070095C Microspheres containing biologically-active components, processes for the preparation and uses |
| 04/25/2000 | CA1340977C Scavenger receptor protein and antibody thereto |
| 04/22/2000 | CA2285749A1 Novel proteins from actinobacillus pleuropneumoniae |
| 04/20/2000 | WO2000022430A2 Neisseria genomic sequences and methods of their use |
| 04/20/2000 | WO2000022142A2 Cell signaling polypeptides and nucleic acids |
| 04/20/2000 | WO2000022135A1 Helicobacter pylori vaccine |
| 04/20/2000 | WO2000022134A2 Test kit for diagnosis of borrelia infection and novel borrelia antigens for the development of vaccines |
| 04/20/2000 | WO2000022120A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 04/20/2000 | WO2000022000A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 04/20/2000 | WO2000021996A2 Methods and compositions for inhibiting neoplastic cell growth |
| 04/20/2000 | WO2000021989A1 Decorin binding proteins dbp a and b and genes encoding them |
| 04/20/2000 | WO2000021983A2 Tuberculosis vaccine and diagnostic reagents based on antigens from the mycobacterium tuberculosis cell |
| 04/20/2000 | WO2000021560A1 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY |
| 04/20/2000 | WO2000021558A1 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 04/20/2000 | WO2000021557A1 Delta 6 fatty acid desaturase |
| 04/20/2000 | WO2000021556A1 Anti hiv compositions comprising immunostimulatory polynucleotides and hiv antigens |
| 04/20/2000 | WO2000021546A1 Preventives/remedies for infection, anti-endotoxin agents, vaccine adjuvants and growth promoters |
| 04/20/2000 | WO2000005347A3 Hepatitis b culture system |
| 04/20/2000 | WO2000004918A3 Agents for the immunotherapy of tumoral diseases |
| 04/20/2000 | WO2000003745A3 Polysaccharide vaccine for staphylococcal infections |
| 04/20/2000 | WO1999064461A3 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 04/20/2000 | WO1999064046A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors |
| 04/20/2000 | WO1999059630A9 Type iii bordetella secretion system |
| 04/20/2000 | WO1999058658A3 Expression vectors for stimulating an immune response and methods of using the same |
| 04/20/2000 | WO1999058611B1 Process for extracting carotenes from carotene-containing materials |
| 04/20/2000 | WO1999057266A3 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 04/20/2000 | DE19847628A1 Outer membrane protein of Helicobacter pylori and DNA sequences, useful in vaccines and for production of diagnostic or therapeutic antibodies |
| 04/20/2000 | CA2347653A1 Novel cell signaling polypeptides and nucleic acids |
| 04/20/2000 | CA2347121A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 04/20/2000 | CA2346713A1 Neisseria genomic sequences and methods of their use |
| 04/20/2000 | CA2346218A1 Tuberculosis vaccine and diagnostic reagents based on antigens from the mycobacterium tuberculosis cell |
| 04/20/2000 | CA2346006A1 Delta 6 fatty acid desaturase |
| 04/20/2000 | CA2344558A1 Anti hiv compositions comprising immunostimulatory polynucleotides and hiv antigens |
| 04/20/2000 | CA2344465A1 Methods and compositions for inhibiting neoplastic cell growth |
| 04/20/2000 | CA2343356A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 04/19/2000 | EP0994187A1 Renin-active substance comprising human prorerin and antibodies to the prorerin profragment |
| 04/19/2000 | EP0994120A1 Process to remove lipopolysaccharides from aqueous solution of proteins |
| 04/19/2000 | EP0993831A2 Compounds and compositions for delivering active agents |
| 04/19/2000 | EP0993469A1 COMPOUNDS ENCODING THE PROTECTIVE M-LIKE PROTEIN OF $i(STREPTOCOCCUS EQUI) AND ASSAYS THEREFOR |
| 04/19/2000 | EP0652775B1 Targeting of liposomes to the blood-brain barrier |
| 04/19/2000 | EP0550561B1 Purification of cytokeratin fragments |
| 04/19/2000 | EP0222835B2 Oral vaccines |
| 04/19/2000 | CN1251132A Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection |
| 04/19/2000 | CN1251130A Isolated viable parasate intestinal cells |
| 04/19/2000 | CN1251042A Identification of broadly reactive DR restricted epitopes |
| 04/18/2000 | US6051693 Human monoclonal antibody which preferentially binds to neoplastic cell over a normal cell of same tissue type; for diagnosis, anticarcinogenic agents and antitumor agents |
| 04/18/2000 | US6051691 Amino acid sequence of protein; for screening bactericides and bacteristats especially targeted to streptococci |
| 04/18/2000 | US6051428 Transducing tumor cells with herpes simplex virus amplicon containing gene coding for cytokines, chemokines, cellular adhesion molecules, or costimulatory molecules which activate b or t-cells for transient expression of the protein |
| 04/18/2000 | US6051426 Vector includes dna sequences encoding pre-s and s region of hepatitis b genome under control of heterologous promoter; for use in chinese hamster ovary cells to produce vaccines having immunogenic properties of hepatitis b surface antigen |
| 04/18/2000 | US6051416 Methods for producing enhanced antigenic Helicobacter sp. |
| 04/18/2000 | US6051413 Valyl tRNA synthetase from Streptococcus pneumoniae |
| 04/18/2000 | US6051412 Glycyl tRNA synthetase from streptococcus pneumoniae |
| 04/18/2000 | US6051410 Self-assembled, defective, nonself-propagating viral particles |
| 04/18/2000 | US6051405 An expression vector containing a dna segment that directs the synthesis of a recombinant fusion protein which is a single chain fab variable region from a modified pseudomonas exotoxin gene; producing improved toxins |
| 04/18/2000 | US6051404 A nucleic acid encoding a protein; vaccines for poultry |
| 04/18/2000 | US6051400 An expression system comprising of a polynucleotide encoding a protein; therapy and diagnosis of kidney diseases, cardiovascular disorders, strokes, alzheimer's disease; anticarcinogenic agents and antiinflammatory agents |
| 04/18/2000 | US6051398 Nucleic acids encoding CR3 polypeptide, vector and transformed cell thereof, and expression thereof |
| 04/18/2000 | US6051387 Methods of determining the presence of a neoplasm with CLNH5- and CLNH11-specific antibodies |
| 04/18/2000 | US6051375 Glycoprotein B of the RFHV/KSHV subfamily of herpes viruses |
| 04/18/2000 | US6051374 Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use |
| 04/18/2000 | US6051240 Separating culture into cells and supernatant; concentrating supernatant; contacting with calcium ions in presence of phosphate ions to form calcium phosphate gel; separating gel to recover supernatant; contacting with ion exchange gel |
| 04/18/2000 | US6051239 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents |
| 04/18/2000 | US6051238 Stabilizers for lyophilized mumps vaccines |
| 04/18/2000 | US6051237 Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| 04/18/2000 | US6051232 Comprising allogenic chimeric major histocompatibility complex class i milecule; to induce tolerance to donor grafts when administered to the recipient at time of transplantation |
| 04/18/2000 | US6051229 Human-human hybridom for neoplasms CLNH5 and CLNH11 specific antibody compositions |
| 04/18/2000 | US6051228 Antibodies against human CD40 |
| 04/18/2000 | US6051227 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 04/18/2000 | US6051226 use of antibodies targeting the MN oncoprotein conjugated to an anticancer therapeutic agent such as drug or toxin for tissue targeted cancer therapy |
| 04/18/2000 | US6051221 BRK protein tyrosine kinase and encoding nucleic acid |
| 04/18/2000 | US6051218 Administering cell expressing interleukin-3 |
| 04/18/2000 | CA2132742C Synthetic peptides and vaccines against parvovirus |
| 04/18/2000 | CA1340963C Gene for encoding a human malaria vaccine antigen |
| 04/13/2000 | WO2000020869A1 Detection of pleiotrophin |
| 04/13/2000 | WO2000020864A1 Immunotherapy of b cell involvement in progression of solid, nonlymphoid tumors |
| 04/13/2000 | WO2000020642A1 Prevention of adhesions |
| 04/13/2000 | WO2000020640A1 A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers |
| 04/13/2000 | WO2000020638A2 Methods and compositions for the diagnosis and therapy of prostate cancer |
| 04/13/2000 | WO2000020621A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 04/13/2000 | WO2000020612A2 Therapeutically active proteins in plants |
| 04/13/2000 | WO2000020609A2 Protective recombinant haemophilus influenzae high molecular weight proteins |
| 04/13/2000 | WO2000020600A1 Avian pneumovirus vaccine and diagnostic agent |
| 04/13/2000 | WO2000020598A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 04/13/2000 | WO2000020592A1 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone |
| 04/13/2000 | WO2000020589A2 PTANs: TESTIS SPECIFIC PROTEINS EXPRESSED IN PROSTATE CANCER |
| 04/13/2000 | WO2000020587A2 Cancer associated antigens and uses therefor |
| 04/13/2000 | WO2000020584A2 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6 |
| 04/13/2000 | WO2000020581A1 Mage-a3 peptides presented by hla class ii molecules |
| 04/13/2000 | WO2000020576A2 Methods and compositions for inducing differentiation and apotosis in cells that overexpess the notch protein |
| 04/13/2000 | WO2000020575A1 Pollinosis-associated gene |
| 04/13/2000 | WO2000020565A1 Enhanced immunogen for inactivated vaccine for infection with japanese encephalitis viruses and process for producing the same |
| 04/13/2000 | WO2000020564A1 T cells mediating an immune response and methods of use |
| 04/13/2000 | WO2000020563A1 Method for inducing cellular immunity and cells with induced cellular immunity |
| 04/13/2000 | WO2000020457A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |